These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16312845)

  • 1. Endocrine manipulation of human prostatic cancer: state of the art.
    Serio M; Calabresi E; Salerno R
    J Chemother; 1989 Jul; 1(4 Suppl):1227-30. PubMed ID: 16312845
    [No Abstract]   [Full Text] [Related]  

  • 2. Endocrine therapy for prostate cancer.
    Labrie F
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):845-72. PubMed ID: 1778180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New aspects of anti-androgenic therapy of prostatic cancer].
    Portnoĭ AS
    Urol Nefrol (Mosk); 1985; (3):69-73. PubMed ID: 3892832
    [No Abstract]   [Full Text] [Related]  

  • 4. Principles of endocrine manipulation in the treatment of prostatic cancer.
    Neumann F
    Prog Clin Biol Res; 1985; 185A():73-98. PubMed ID: 3898136
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of advanced cancer of the prostate.
    Orovan WL
    Can J Surg; 1989 Sep; 32(5):315-6. PubMed ID: 2670160
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines on the management of prostate cancer.
    Ago CT
    Clin Oncol (R Coll Radiol); 1999; 11(5):361. PubMed ID: 10591828
    [No Abstract]   [Full Text] [Related]  

  • 7. Interview with Professor Ulf Tunn: LHRHa: What's new? Interview by Christine McKillop.
    Tunn U
    Eur Urol; 2007 Jan; 51(1):275-7. PubMed ID: 17023109
    [No Abstract]   [Full Text] [Related]  

  • 8. [Role of hormonotherapy in the treatment of metastatic prostate cancer].
    Lebret T; Méjean A
    Prog Urol; 2008 Nov; 18 Suppl 7():S332-7. PubMed ID: 19070812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine therapy: predictors of response to prostatic cancer.
    Geller J; Albert JD
    Semin Urol; 1983 Nov; 1(4):291-7. PubMed ID: 6399615
    [No Abstract]   [Full Text] [Related]  

  • 10. [High risk prostate cancer results of one year RT-HT].
    Delaporte V; Muracciole X; Lechevalier E; Bastide C; Cowen D; Rossi D; Coulange C
    Prog Urol; 2005 Dec; 15(6 Suppl 1):1256-61. PubMed ID: 16734214
    [No Abstract]   [Full Text] [Related]  

  • 11. [GnRH analogues in the treatment of prostate cancer].
    Zerbib M
    Rev Prat; 2005; Spec. No():35-41. PubMed ID: 15822870
    [No Abstract]   [Full Text] [Related]  

  • 12. Luteinizing hormone-releasing hormone analogues and hormone ablation for prostate cancer: state of the art.
    Schally AV
    BJU Int; 2007 Jul; 100 Suppl 2():2-4. PubMed ID: 17594347
    [No Abstract]   [Full Text] [Related]  

  • 13. Current status of neoadjuvant therapy in localized prostate cancer.
    Witjes WP; Oosterhof GO; Schaafsma HE; Debruyne FM
    Prostate; 1995 Dec; 27(6):297-303. PubMed ID: 7501541
    [No Abstract]   [Full Text] [Related]  

  • 14. Androgen deprivation therapy for prostate cancer.
    Bahnson R
    J Urol; 2007 Oct; 178(4 Pt 1):1148. PubMed ID: 17698142
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer of the prostate: endocrine factors.
    Griffiths K; Davies P; Eaton CL; Harper ME; Peeling WB; Turkes AO; Turkes A; Wilson DW; Pierrepoint CG
    Oxf Rev Reprod Biol; 1987; 9():192-259. PubMed ID: 3324009
    [No Abstract]   [Full Text] [Related]  

  • 16. Advanced prostate cancer. Hormonal treatment.
    de la Haba-Rodríguez J
    Tunis Med; 2005 Dec; 83 Suppl 12():71-3. PubMed ID: 16430072
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment.
    Pinkawa M
    J Urol; 2010 Feb; 183(2):639; discussion 639-40. PubMed ID: 20018310
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment.
    Williams SG
    J Urol; 2010 Feb; 183(2):639; discussion 639-40. PubMed ID: 20018309
    [No Abstract]   [Full Text] [Related]  

  • 19. The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.
    Mosca A; Berruti A; Russo L; Torta M; Dogliotti L
    J Endocrinol Invest; 2005; 28(11 Suppl International):141-5. PubMed ID: 16625864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel concepts in androgen receptor blockade.
    Hsieh AC; Ryan CJ
    Cancer J; 2008; 14(1):11-4. PubMed ID: 18303477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.